Articles dans des revues avec comité de lecture (170)
  1. 114. Van Antwerpen, P., Zouaoui Boudjeltia, K., Furtmüller, P. G., Dieu, M., Delporte, C., Raes, M., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., Neve, J., & Obinger, C. (2010). Oxidation of cyanide to cyanate by myeloperoxidase: A new route for apolipoprotein carbamylation? Atherosclerosis. Supplement, 11(2).
  2. 115. Delporte, C., Van Antwerpen, P., Zouaoui Boudjeltia, K., Noyon, C., Calay, D., Reye, F., Rousseau, A., Raes, M., Vanhaeverbeek, M., Ducobu, J., & Neve, J. (2010). Specific oxidation of apolipoprotein-B-100 by myeloperoxidase. Atherosclerosis. Supplement, 11(2).
  3. 116. Zouaoui Boudjeltia, K., Durez, P., Oberweis, D., Guillaume, M., Remacle, C., Cauchie, P., Vanhaeverbeek, M., Brohée, D., Ducobu, J., & Gregoir, C. (2010). Effects of raloxifene treatment on the phenotype of blood monocytes. Canadian journal of physiology and pharmacology, 88(5), 601-605. doi:10.1139/y10-002
  4. 117. Van Antwerpen, P., Slomianny, M.-C., Zouaoui Boudjeltia, K., Delporte, C., Faid, V., Calay, D., Rousseau, A., Moguilevsky, N., Raes, M., Vanhamme, L., Furtmüller, P. G., Obinger, C., Vanhaeverbeek, M., Neve, J., & Michalski, J.-C. (2010). Glycosylation pattern of mature dimeric leukocyte and recombinant monomeric myeloperoxidase: glycosylation is required for optimal enzymatic activity. The Journal of biological chemistry, 285(21), 16351-16359. doi:10.1074/jbc.M109.089748
  5. 118. Roumeguere, T., Zouaoui Boudjeltia, K., Babar, S., Nuyens, V., Rousseau, A., Van Antwerpen, P., Ducobu, J., Wespes, E., & Vanhaeverbeek, M. (2010). Effects of phosphodiesterase inhibitors on the inflammatory response of endothelial cells stimulated by myeloperoxidase-modified low-density lipoprotein or tumor necrosis factor alpha. European urology, 57(3), 522-528. doi:10.1016/j.eururo.2009.01.030
  6. 119. Lelubre, C., Zouaoui Boudjeltia, K., Van Antwerpen, P., Vanhaeverbeek, M., & Roumeguere, T. (2010). Phosphodiesterase Inhibitors in the Treatment of Inflammatory Disorders: A Narrative Review. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 9(2), 1-15.
  7. 120. Franck, T., Kohnen, S. S., Zouaoui Boudjeltia, K., Van Antwerpen, P., Bosseloir, A., Niesten, A., Gach, O., Nys, M., Deby-Dupont, G., & Serteyn, D. (2009). A new easy method for specific measurement of active myeloperoxidase in human biological fluids and tissue extracts. Talanta, 80(2), 723-729. doi:10.1016/j.talanta.2009.07.052
  8. 121. Roumeguere, T., Van Antwerpen, P., Zouaoui Boudjeltia, K., Vanhaeverbeek, M., & Wespes, E. (2009). Maladies cardiovasculaires, dysfonction érectile et myéloperoxydase. Angéiologie, 61(3), 88-92.
  9. 122. Aminian, A., Zouaoui Boudjeltia, K., Babar, S., Van Antwerpen, P., Lefebvre, P., Crasset, V., Leone, A., Ducobu, J., Friart, A., & Vanhaeverbeek, M. (2009). Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction. European journal of internal medicine, 20(5), 527-532. doi:10.1016/j.ejim.2009.05.008
  10. 123. Roumeguere, T., Zouaoui Boudjeltia, K., Hauzeur, C., Schulman, C., Vanhaeverbeek, M., & Wespes, E. (2009). Is there a rationale for the chronic use of phosphodiesterase-5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia? BJU international, 104(4), 511-517. doi:10.1111/j.1464-410X.2009.08418.x
  11. 124. Kerkhofs, M., Faraut, B., Zouaoui Boudjeltia, K., & Vanhaeverbeek, M. (2009). Restriction de sommeil et risque cardiovasculaire. Medecine du Sommeil, 6(3), 95-98. doi:10.1016/j.msom.2009.10.002
  12. 125. Mendes Dos Santos, S., Candi, A., Vansteenbrugge, M., Pignon, M.-R., Bult, H., Zouaoui Boudjeltia, K., Munaut, C., & Raes, M. (2009). Microarray analyses of the effects of NF-kappaB or PI3K pathway inhibitors on the LPS-induced gene expression profile in RAW264.7 cells: synergistic effects of rapamycin on LPS-induced MMP9-overexpression. Cellular signalling, 21(7), 1109-1122. doi:10.1016/j.cellsig.2009.02.025
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Suivant >>